1.65000 USD
0.02
1.23%
Last update Apr 1, 3:59 PM EDT
Post-market
Day range
1.62000
1.65000
Previous close
1.63000
Open
1.63000
Access this stock data via API
Subscribe
Aptose Biosciences Inc.
1.65
0.02
1.23%

Financials

Income statement

Fiscal date Mar 2025 Dec 2024 Sep 2024 Jun 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 2.4M -457K 4.7M 4.4M
Selling general and admin 3.1M 2.6M 2.3M 2.9M
Other operating expenses
Operating income -5.5M -2.2M -7.0M -7.3M
Non operating interest income
Income 131K 12K 93K
Expense 84K
Other income expense 2K 678K
Pretax income -5.5M -1.6M -7.0M -7.3M
Tax provision
Net income -5.5M -1.6M -7.0M -7.3M
Basic EPS -2.6 -11.1 -12.9
Diluted EPS -2.6 -11.1 -12.9
Basic average shares 2.1M 618.7K 558.5K
Diluted average shares 2.1M 618.7K 558.5K
EBITDA -5.4M -1.7M -6.9M -7.2M
Net income from continuing op. -5.5M -1.6M -7.0M -7.3M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 31 minutes

19:29
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).